成人劈离式右半肝移植联合部分脾切除术治疗乙型病毒性肝炎肝硬化合并重度脾功能亢进的临床价值

Clinical value of adult right lobe split liver transplantation combined with partial splenectomy for hepatitis B related cirrhosis with severe hypersplenism

  • 摘要:
    目的 探讨成人劈离式右半肝移植联合部分脾切除术治疗乙型病毒性肝炎肝硬化合并重度脾功能亢进的临床价值。
    方法 采用回顾性描述性研究方法。收集2024年10月哈尔滨医科大学附属第一医院收治的1例44岁男性乙型病毒性肝炎肝硬化合并重度脾功能亢进患者的临床资料。患者行成人劈离式右半肝移植联合部分脾切除术。观察指标:(1)手术情况。(2)随访情况。
    结果 (1)手术情况:患者顺利行成人劈离式右半肝移植联合部分脾切除术。患者手术总时间为570 min,血管重建时间为47 min,无肝期为45 min,部分脾切除术时间为70 min,术中出血量约为800 mL。移植物实际质量为766 g,移植物受者体重比为0.87%,右半肝体积与标准肝体积比为41%。移植物再灌注后,初始门静脉压力为24 mmHg(1 mmHg=0.133 kPa);切除患者脾上极约60%脾脏后,门静脉压力为13 mmHg,血流动力学稳定。患者术后肝功能恢复顺利,转氨酶及总胆红素均呈下降趋势,白细胞及血小板计数回升明显。患者腹腔积液引流量于术后第1天最多(1 600 mL),随后逐渐下降,术后第9天引流量<100 mL后拔除腹腔引流管。患者术后定期行移植肝超声检查未见异常。患者CT检查肝脏三维重建示移植肝体积逐渐增大(术后第6天为1 211 cm³,第15天为1 492 cm³)。患者术后第14天行T管造影检查未见异常,隔日夹闭T管。术后第3天起给予低分子肝素抗凝治疗;免疫抑制方案采用他克莫司、麦考酚钠联合甲泼尼龙。患者于术后第18天顺利出院,期间未发生排斥反应及感染并发症。(2)随访情况:患者术后随访14个月,移植物功能稳定,超声检查示移植物血流信号正常且无血栓形成。CT检查脾脏三维重建示脾脏体积较术后早期持续缩小(术后第6天为1 376 cm³,第56天为1 042 cm³,术后14个月为895 cm³)。患者主要肝功能指标及白细胞、血小板计数均无异常,外周血免疫球蛋白分类及定量正常,随访期间未发生感染相关并发症。
    结论 成人劈离式右半肝移植联合部分脾切除术治疗乙型病毒性肝炎肝硬化合并重度脾功能亢进,可安全、有效地调控门静脉血流动力学,纠正脾功能亢进,在免疫保护与血栓预防方面具有临床优势。

     

    Abstract:
    Objective To investigate the clinical value of adult right lobe split liver transplantation combined with partial splenectomy in the treatment of hepatitis B related cirrhosis with severe hypersplenism.
    Methods The retrospective and descriptive study was conducted. The clinical data of a 44-year-old male patient with hepatitis B related cirrhosis and severe hypersplenism who was admitted to The First Affiliated Hospital of Harbin Medical University in October 2024 were collected. The patient underwent adult right lobe split liver transplantation combined with partial splenectomy. Observation indicators: (1) surgical conditions; (2) follow-up.
    Results (1) Surgical conditions: the patient successfully underwent adult right lobe split liver transplantation combined with partial splenectomy. The total operation time was 570 minutes, vascular reconstruction time was 47 minutes, anhepatic phase was 45 minutes, and partial splenectomy time was 70 minutes.The volume of intraoperative blood loss was approximately 800 mL. The actual graft weight was 766 g, with a graft-to-recipient weight ratio of 0.87% and a ratio of right lobe graft volume to standard liver volume of 41%. After graft reperfusion, the initial portal vein pressure (PVP) was 24 mmHg (1 mmHg=0.133 kPa). Approximately 60% of the superior splenic pole was resected, reducing the PVP to 13 mmHg with stable hemodynamics. Postoperative liver function of the patient recovered uneventfully, with aminotransferases and total bilirubin showing downward trends, while white blood cell and platelet counts increased significantly. Abdominal drainage was highest on postoperative day 1 (1 600 mL), gradually decreased thereafter, and the drainage tube was removed on postoperative day 9 when drainage output was <100 mL. Regular ultrasonography showed no abnormalities in the graft. Three-dimensional reconstruction of computed tomography revealed gradual graft volume increase (1 211 cm³ on postoperative day 6, 1 492 cm³ on postoperative day 15). T-tube cholangiography on postoperative day 14 showed no abnormalities, and the T-tube was clamped on the following day. Low molecular weight heparin anticoagulation was initiated on postoperative day 3. The immunosuppressive regimen consisted of tacrolimus, mycophenolate sodium, and methylprednisolone. The patient was discharged uneventfully on postoperative day 18 without rejection or infectious complications.(2) Follow-up: during the 14-month follow-up, graft function remained stable. Ultrasonography demonstrated normal graft blood flow without thrombosis. Three-dimensional reconstruction of computed tomography showed continuous reduction of splenic volume compared to the early postoperative period (1 376 cm³ on postoperative day 6, 1 042 cm³ on postoperative day 56, and 895 cm³ at 14 month postoperatively). Major liver function indicators, white blood cell and platelet counts remained normal. Peripheral blood immunoglobulin classification and quantification were normal. No infection-related complications occurred during the follow-up period.
    Conclusion Adult right lobe split liver transplantation combined with partial splenectomy for hepatitis B related cirrhosis with severe hypersplenism can safely and effectively regulate portal hemodynamics, correct hypersplenism, and offer clinical advantages in terms of immunoprotection and thrombosis prevention.

     

/

返回文章
返回